샘플 요청 목록

 카트 문의
시장보고서
상품코드
1793714

세계의 공포증 치료 시장

Phobia Treatment
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 374 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

공포증 치료 세계 시장은 2030년까지 24억 달러에 달할 전망

2024년에 19억 달러로 추정되는 공포증 치료 세계 시장은 2024년부터 2030년까지 CAGR 4.0%로 성장하여 2030년에는 24억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 동물공포증은 CAGR 5.2%를 기록하며 분석 기간 종료시에는 7억 7,150만 달러에 달할 것으로 예측됩니다. 고소공포증 분야의 성장률은 분석 기간 동안 CAGR 2.8%로 추정됩니다.

미국 시장은 5억 2,700만 달러로 추정, 중국은 CAGR 7.5%로 성장 예측

미국의 공포증 치료 시장은 2024년에 5억 2,700만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간인 2024-2030년 CAGR 7.5%로 2030년까지 5억 240만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 1.5%와 3.1%로 예측됩니다. 유럽에서는 독일이 CAGR 2.3%로 성장할 것으로 예측됩니다.

세계의 공포증 치료 시장 - 주요 동향과 촉진요인 정리

공포증 치료에 대한 수요가 인구통계학적, 지역적으로 증가하는 이유는 무엇일까?

공포증은 특정 대상, 상황, 활동에 대한 강렬하고 비합리적인 두려움으로 분류되며, 전문가의 개입이 필요한 심각한 정신건강 상태로 인식되고 있습니다. 선진국이든 개발도상국이든 정신건강에 대한 인식이 높아지면서 사회공포증, 광장공포증, 고소공포증, 거미공포증, 비행공포증, 폐쇄공포증 등 다양한 종류의 공포증에 대한 치료를 찾는 사람들이 늘고 있습니다. 과거 심리적 상태에 대한 낙인이 점차 줄어들면서 더 많은 사람들이 진단을 받고 치료를 받고 있습니다. 이와 함께 의료 시스템과 정부는 정신건강 서비스를 일차 진료에 통합하여 공포증 치료를 보다 쉽게 이용할 수 있도록 하고 있습니다. 또한, COVID-19 팬데믹과 같은 세계 건강 문제와 사회적 압력은 불안 관련 장애의 급증에 기여하고 있으며, 치료를 필요로 하는 사람들의 풀을 더욱 확대시키고 있습니다. 디지털 헬스 및 원격 정신의학으로의 전환은 치료사가 농촌 지역과 소외된 사람들에게 다가갈 수 있게 하여 접근성의 격차를 해소하고 조기 개입을 촉진하고 있습니다. 학교, 직장, 커뮤니티 센터에서는 조기 발견과 치료에 대한 편견을 없애기 위해 검진 및 교육 프로그램을 제공하는 곳이 늘고 있습니다. 문화적 장벽이 사라지고 많은 국가에서 심리적 질환에 대한 보험 적용이 개선됨에 따라 공포증 치료의 환자층은 계속 넓어지고 있습니다. 이처럼 공포증이 정당한 질병으로 인식되고 치료 접근성이 향상되면서 치료 솔루션 세계 시장 확대에 크게 기여하고 있습니다.

치료와 기술의 혁신은 공포증 치료에 어떤 혁명을 가져오고 있는가?

기술의 발전과 치료법의 혁신은 공포증의 진단, 관리, 치료 방법을 크게 변화시키고 있습니다. 전통적인 인지행동치료(CBT)는 대부분의 공포증 치료의 표준이 되고 있지만, 최근 개선된 접근법은 보다 개인화되고 효과적인 치료법으로 발전하고 있습니다. 가상현실 노출 치료(VRET)는 특히 비행기 공포증, 고소공포증, 대중 연설 공포증 등 특정 공포증 치료에 큰 지지를 받고 있습니다. VRET는 통제된 환경을 시뮬레이션함으로써 환자가 안전하고 구조화된 환경에서 두려움을 극복하고 감각을 마비시킬 수 있도록 도와줍니다. 또한, AI 기반 정신건강 플랫폼은 현재 알고리즘을 사용하여 불안 수준을 평가하고, 치료 계획을 제안하고, 안내된 치료 세션을 제공하는 등 AI 기반 정신건강 플랫폼이 등장하고 있습니다. 노출 훈련, 기분 추적, 가상 코칭을 통합한 모바일 앱은 환자가 전문가 세션 사이에 자기 주도적 치료를 할 수 있도록 돕습니다. 약리학적인 발전도 치료에 기여하고 있으며, 선택적 세로토닌 재흡수 억제제(SSRI), 베타차단제, 항불안제 등이 급성 증상을 완화하고 치료 결과를 지원하기 위해 선택적으로 사용되고 있습니다. 기능적 MRI와 뉴로피드백 기술은 임상의들이 공포증의 신경학적 메커니즘을 더 깊이 이해하는 데 도움이 되고 있으며, 보다 표적화된 개입의 문을 열어줄 수 있습니다. 집단치료나 마음챙김에 기반한 인지치료도 특히 동료들과의 교류와 정서적 확인의 혜택을 누리는 환자들 사이에서 인기를 끌고 있습니다. 신경과학, 디지털 치료학, 심리학 연구의 융합은 임상과 비임상을 막론하고 다양한 환자들의 요구에 부응하는 보다 견고하고 반응성이 높은 공포증 치료 생태계를 만들어가고 있습니다.

공포증 치료의 접근성과 보급을 형성하는 사회적 요인과 의료적 요인은 무엇인가?

공포증 치료의 접근성과 보급은 사회적 태도, 의료 인프라, 교육 보급 활동의 조합에 큰 영향을 받습니다. 많은 중저소득 국가에서 정신건강 관리는 여전히 자금이 부족하고 공중 보건 시스템과의 통합이 미흡하여 자격을 갖춘 치료사 및 정신과 의사가 제한되어 있습니다. 이러한 부족은 정신질환에 대한 문화적 금기와 오해로 인해 더욱 악화되는 경우가 많으며, 개인이 자신의 두려움을 인정하고 도움을 요청하는 것을 방해합니다. 반면, 정신건강 프로그램이 잘 갖춰져 있고, 훈련된 전문가가 있으며, 보험이 적용되는 고소득 국가에서는 치료율이 월등히 높고, 장기적인 결과도 양호한 것으로 나타났습니다. 공포증에 대한 사회적 인식을 바꾸고 조기 진단을 유도하는 데 있어 정부 기관과 비정부 기관이 지원하는 인식 개선 캠페인이 매우 중요한 역할을 하고 있습니다. 학교나 대학에서 상담 서비스를 이용할 수 있게 되었고, 이는 사회공포증이나 성과와 관련된 공포증에 빠지기 쉬운 젊은 층에게 접근하는 데 필수적입니다. 고용주들 또한 치료되지 않은 불안장애가 생산성과 결근에 미치는 영향을 인식하고 있으며, 많은 기업들이 정신건강 혜택과 직원 지원 프로그램을 건강관리 패키지에 포함시키고 있습니다. 그러나 농촌과 도시 간 접근성, 언어의 장벽, 의료비 부담 등의 측면에서 격차가 있어 정신보건의료의 형평성이 시급한 과제로 대두되고 있습니다. 이러한 격차를 해소하기 위해서는 원격 치료 인프라, 지역 기반 개입, 정신건강 교육에 대한 지속적인 투자가 필수적입니다. 의료 시스템이 보다 통합적인 접근 방식으로 진화함에 따라 일상적인 의료 서비스에 심리 치료를 통합하는 것은 전 세계적으로 공포증 치료의 범위와 영향력을 확대하는 데 필수적입니다.

공포증 치료 솔루션의 세계 확장 및 혁신의 원동력은?

공포증 치료 시장의 성장은 과학의 발전, 환자의 행동, 세계 의료 정책과 관련된 여러 요인에 의해 발생합니다. 주요 요인 중 하나는 불안장애의 유병률 증가이며, 그 중 공포증이 큰 비중을 차지하고 있습니다. 진단 도구와 스크리닝 방법이 더욱 정확하고 광범위하게 사용됨에 따라 더 많은 사례를 식별하고 적절한 치료 경로로 안내할 수 있게 되었습니다. 원격의료 서비스와 정신건강 앱의 확대는 치료를 보다 친숙하고 눈에 띄지 않게 만들어 기술에 익숙한 젊은 세대와 원격지에 사는 사람들을 포함한 다양한 계층에게 어필하고 있습니다. 임상적 측면에서는 노출 요법, 가상현실 환경, 신경 자극 요법 등의 혁신이 보다 몰입감 있고 개별화된 치료 경험을 만들어내고 있습니다. 의약품 개발도 한몫을 하고 있으며, 항불안제의 내약성과 유효성이 개선되면서 환자의 순응도와 치료 성적이 향상되고 있습니다. 정신건강이 공중보건의 우선순위라는 개발도상국 정부의 인식에 따라 자금이 증가하고, 보편적 의료 모델에 정신건강 서비스가 포함되었으며, 공포증과 불안 관리를 위한 대상 프로그램이 개발되었습니다. 직장 내 건강 증진에 대한 노력과 정신건강 서비스에 대한 보험 적용의 증가는 접근성이 높고 비용 효율적인 치료에 대한 수요를 더욱 자극하고 있습니다. 이와 함께 소비자의 선호도가 비침습적, 치료 기반, 통합적 치료 옵션으로 이동하고 있으며, 마음챙김, 전인적 상담, 디지털 CBT 플랫폼의 성장을 가져오고 있습니다. 이러한 흐름이 맞물리면서 역동적이고 혁신 주도적인 환경이 조성되어 세계 공포증 치료 시장은 빠르게 발전하고 있습니다.

부문

공포증 유형(동물공포증, 고소공포증, 광장공포증, 폐소공포증, 사회공포증, 기타 공포증 유형), 치료법(테라피, 약물요법), 최종사용자(병원 최종사용자, 정신과 클리닉 최종사용자, 공포증 치료 센터 최종사용자, 기타 최종사용자)

조사 대상 기업 사례

  • AbleTo
  • Ada Health
  • Alkermes
  • AMW GmbH
  • AppliedVR
  • Atai Life Sciences
  • Big Health
  • Braingaze
  • Cerebral
  • Compass Pathways
  • Headspace Health
  • Limbix
  • Lyra Health
  • MindMaze
  • Mindstrong
  • Modern Health
  • Novartis
  • Talkspace
  • Teladoc Health
  • Woebot Health

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.26

Global Phobia Treatment Market to Reach US$2.4 Billion by 2030

The global market for Phobia Treatment estimated at US$1.9 Billion in the year 2024, is expected to reach US$2.4 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Zoophobia, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$771.5 Million by the end of the analysis period. Growth in the Acrophobia segment is estimated at 2.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$527.0 Million While China is Forecast to Grow at 7.5% CAGR

The Phobia Treatment market in the U.S. is estimated at US$527.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$502.4 Million by the year 2030 trailing a CAGR of 7.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Phobia Treatment Market - Key Trends & Drivers Summarized

Why Is the Demand for Phobia Treatment Rising Across Demographics and Regions?

Phobias, categorized as intense and irrational fears of specific objects, situations, or activities, are increasingly being recognized as serious mental health conditions requiring professional intervention. With growing awareness around mental health, both in developed and developing regions, more individuals are seeking treatment for various types of phobias, including social phobia, agoraphobia, specific phobias like fear of heights, spiders, flying, or enclosed spaces. The stigma that once surrounded psychological conditions is gradually decreasing, which has encouraged more people to pursue diagnosis and therapy. In parallel, healthcare systems and governments are integrating mental health services into primary care, making phobia treatment more accessible. Furthermore, global health challenges and social pressures, such as the COVID-19 pandemic, have contributed to a spike in anxiety-related disorders, further expanding the pool of individuals requiring treatment. The shift toward digital health and telepsychiatry has also allowed therapists to reach rural and underserved populations, bridging access gaps and encouraging early intervention. Schools, workplaces, and community centers are increasingly offering screenings and educational programs that promote early identification and destigmatize treatment. As cultural barriers continue to erode and insurance coverage for psychological conditions improves in many countries, the patient base for phobia treatment continues to widen. This growing recognition of phobias as legitimate medical conditions, combined with enhanced access to care, is significantly driving the expansion of the global market for treatment solutions.

How Are Innovations in Therapy and Technology Revolutionizing Phobia Treatment?

Technological advancements and therapeutic innovations are profoundly transforming how phobias are diagnosed, managed, and treated. Traditional cognitive-behavioral therapy (CBT) remains the gold standard for most phobia treatments, but modern enhancements are making these approaches more personalized and effective. Virtual reality exposure therapy (VRET) is gaining significant traction, especially for treating specific phobias like fear of flying, heights, or public speaking. By simulating controlled environments, VRET allows patients to confront and desensitize their fears in a safe, structured setting. Additionally, AI-powered mental health platforms are now using algorithms to assess anxiety levels, suggest treatment plans, and even provide guided therapy sessions. Mobile apps with built-in exposure exercises, mood tracking, and virtual coaching have empowered patients to engage in self-directed therapy between professional sessions. Pharmacological advancements are also contributing to treatment, with selective serotonin reuptake inhibitors (SSRIs), beta blockers, and anxiolytics being used selectively to reduce acute symptoms and support therapy outcomes. Functional MRI and neurofeedback technologies are helping clinicians gain deeper insights into the neurological mechanisms behind phobias, potentially opening doors to even more targeted interventions. Group therapy and mindfulness-based cognitive therapy are also gaining popularity, particularly among patients who benefit from peer interaction and emotional validation. The convergence of neuroscience, digital therapeutics, and psychological research is creating a more robust and responsive ecosystem for phobia treatment that caters to diverse patient needs across clinical and non-clinical settings.

What Societal and Healthcare Factors Shape the Accessibility and Uptake of Phobia Treatment?

The accessibility and adoption of phobia treatment are heavily influenced by a combination of societal attitudes, healthcare infrastructure, and educational outreach. In many low- and middle-income countries, mental health care is still underfunded and poorly integrated into public health systems, resulting in limited availability of qualified therapists and psychiatrists. This shortage is often exacerbated by cultural taboos and misconceptions surrounding mental illness, which discourage individuals from acknowledging their fears or seeking help. In contrast, high-income countries with robust mental health programs, trained professionals, and insurance coverage have significantly higher treatment rates and better long-term outcomes. Public awareness campaigns, supported by both governmental and non-governmental organizations, have played a pivotal role in reshaping societal perceptions about phobias and encouraging early diagnosis. Schools and universities are increasingly providing access to counseling services, which is essential in reaching younger populations who are vulnerable to social and performance-related phobias. Employers are also recognizing the impact of untreated anxiety disorders on productivity and absenteeism, leading many to include mental health benefits and employee assistance programs in their healthcare packages. However, disparities persist in terms of rural versus urban access, language barriers, and affordability, making equity in mental health care a pressing issue. Continued investments in teletherapy infrastructure, community-based interventions, and mental health education are crucial to closing these gaps. As healthcare systems evolve toward a more holistic approach, the integration of psychological care into routine health services will be vital in expanding the reach and impact of phobia treatment worldwide.

What Drives the Global Expansion and Innovation in Phobia Treatment Solutions?

The growth in the phobia treatment market is driven by several factors related to scientific progress, patient behavior, and the global health policy landscape. One of the primary drivers is the increasing prevalence of anxiety disorders, with phobias comprising a substantial share of these conditions. As diagnostic tools and screening practices become more precise and widespread, more cases are being identified and funneled into appropriate treatment pathways. The expansion of telehealth services and mental health apps has made therapy more accessible and discreet, appealing to a broader demographic that includes tech-savvy younger generations and individuals in remote regions. On the clinical side, innovations in exposure-based therapy, virtual reality environments, and neurostimulation are creating more immersive and individualized treatment experiences. Pharmaceutical developments are also playing a role, with improved tolerability and efficacy of anti-anxiety medications enhancing patient compliance and outcomes. Governmental recognition of mental health as a public health priority has led to increased funding, inclusion of mental health services in universal healthcare models, and the development of targeted programs for phobia and anxiety management. The rise of workplace wellness initiatives and insurance coverage for mental health services further stimulates demand for accessible and cost-effective treatments. In parallel, consumer preferences are shifting toward non-invasive, therapy-based, and integrative treatment options, leading to the growth of mindfulness, holistic counseling, and digital CBT platforms. These intersecting trends are fostering a dynamic, innovation-driven environment that is propelling the global phobia treatment market forward at an accelerating pace.

SCOPE OF STUDY:

The report analyzes the Phobia Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Phobia Type (Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia, Other Phobia Types); Treatment (Therapy , Medication); End-Use (Hospitals End-Use, Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • AbleTo
  • Ada Health
  • Alkermes
  • AMW GmbH
  • AppliedVR
  • Atai Life Sciences
  • Big Health
  • Braingaze
  • Cerebral
  • Compass Pathways
  • Headspace Health
  • Limbix
  • Lyra Health
  • MindMaze
  • Mindstrong
  • Modern Health
  • Novartis
  • Talkspace
  • Teladoc Health
  • Woebot Health

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Phobia Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Awareness of Mental Health Issues Propels Demand for Effective Phobia Treatment Options
    • Increased Willingness to Seek Help Expands the Addressable Market for Evidence-Based Therapies
    • Advancements in Cognitive Behavioral Therapy (CBT) Strengthen the Business Case for Structured Phobia Treatment
    • Growth in Digital Therapeutics and App-Based CBT Solutions Drives Adoption in Younger Populations
    • Virtual Reality (VR) Exposure Therapy Throws the Spotlight on Immersive, Technology-Driven Treatment Models
    • Telepsychiatry and Remote Counseling Services Accelerate Access to Specialized Phobia Treatment Providers
    • Integration of AI and Personalized Therapy Tools Enhances Engagement and Clinical Outcomes
    • Rising Demand for Non-Pharmacological Interventions Spurs Development of Mindfulness and Relaxation-Based Therapies
    • Increased Use of SSRIs and Beta Blockers in Severe Cases Sustains Pharmacological Treatment Demand
    • Stigma Reduction Campaigns and Mental Health Advocacy Strengthen Public Receptiveness to Treatment
    • Growth of Private Mental Health Clinics and Wellness Platforms Fuels Availability of Specialized Phobia Care
    • Clinical Research in Neuroplasticity and Fear Extinction Drives Innovation in Next-Generation Therapies
    • Global Digital Health Investments Create Momentum for Scalable, Low-Cost Treatment Delivery Platforms
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Phobia Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Phobia Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Phobia Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Phobia Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Zoophobia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Zoophobia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Zoophobia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Acrophobia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Acrophobia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Acrophobia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Agoraphobia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Agoraphobia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Agoraphobia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Claustrophobia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Claustrophobia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Claustrophobia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Social Phobia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Social Phobia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Social Phobia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Phobia Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Phobia Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Phobia Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Psychiatry Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Psychiatry Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Psychiatry Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Phobia Treatment Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Phobia Treatment Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Phobia Treatment Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Medication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • JAPAN
    • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • CHINA
    • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: China 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: China 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: China 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • EUROPE
    • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Phobia Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Phobia Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Phobia Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • FRANCE
    • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: France 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: France 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: France 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • GERMANY
    • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Spain 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Spain 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Russia 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Russia 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Phobia Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Phobia Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Phobia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Australia 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Australia 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • INDIA
    • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 173: India Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: India 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: India 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: India 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: South Korea 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: South Korea 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Phobia Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Phobia Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Phobia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Latin America 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Latin America 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Argentina 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 220: Argentina 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 226: Brazil 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 229: Brazil 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 235: Mexico 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 238: Mexico 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Phobia Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Phobia Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Phobia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 256: Middle East 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 259: Middle East 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 265: Iran 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 268: Iran 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 274: Israel 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 277: Israel 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 292: UAE 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 295: UAE 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
  • AFRICA
    • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 310: Africa 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 313: Africa 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제